Skip to main content

Table 1 Characteristics of biopsied patients

From: The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer

Characteristics

n = 63 (%)

  Age (years)

53.1 (30 to 73)

  RFS (months)

34.8 (4 to 190)

Tumor size

  T1

32 (50.8%)

  T2

27 (42.9%)

  T3

4 (6.3%)

Lymph node staging

  0

24 (38.1%)

  1

24 (38.1%)

  2

9 (14.3%)

  3

6 (9.5%)

Histologic type

  IDC

62 (98.4%)

  Apocrine carcinoma

1 (1.6%)

Molecule subtype

  Luminal

32 (50.8%)

  TNBC

24 (38.1%)

  HER2 positive

7 (11.1%)

Adjuvant chemotherapy

  Yes

47 (74.6%)

  No

16 (25.4%)

Adjuvant endocrine therapy

  Yes

32 (50.8%)

  No

31 (49.2%)

Adjuvant radiotherapy

  Yes

29 (46.0%)

  No

34 (54.0%)

Location of suspicious lesions

  Visceraa

48 (76.2%)

  Soft tissuesb

15 (23.8%)

Number of suspicious lesions

  Single

11 (17.5%)

  Multiple

52 (82.5%)

  1. Abbreviations: IDC, invasive ductal carcinoma, RFS, relapse free survival, TNBC, triple negative breast cancer, aViscera: liver, pleura, lung, and ovary; bSoft tissues: lymph node and soft tissue.